Matt Kaplan's Insider Trades & SAST Disclosures
Matt Kaplan's most recent trade in Great Elm Capital Corp was a trade of 42,121 Common Stock done . Disclosure was reported to the exchange on Sept. 20, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Matt Kaplan.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Great Elm Capital Corp | Matt Kaplan | CEO and President | Other type of transaction at price $ 0.00 per share. | 20 Sep 2024 | 42,121 | 92,789 (0%) | 0% | 0 | Common Stock | |
| Nuvectis Pharma Inc | Matthew L. Kaplan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 30,000 | 83,760 | - | 0 | Common Stock | |
| Nuvectis Pharma Inc | Matthew L. Kaplan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 18,000 | 53,760 | - | 0 | Common Stock | |
| Great Elm Capital Corp | Matt Kaplan | CEO and President | Purchase of securities on an exchange or from another person at price $ 9.29 per share. | 10 Mar 2023 | 1,100 | 12,000 (0%) | 0% | 9.3 | 10,219 | Common Stock |
| Great Elm Capital Corp | Matt Kaplan | CEO and President | Purchase of securities on an exchange or from another person at price $ 9.13 per share. | 07 Mar 2023 | 5,020 | 7,020 (0%) | 0% | 9.1 | 45,833 | Common Stock |
| Great Elm Capital Corp | Matt Kaplan | CEO and President | Purchase of securities on an exchange or from another person at price $ 9.46 per share. | 07 Mar 2023 | 2,201 | 9,221 (0%) | 0% | 9.5 | 20,821 | Common Stock |
| Great Elm Capital Corp | Matt Kaplan | CEO and President | Purchase of securities on an exchange or from another person at price $ 9.41 per share. | 07 Mar 2023 | 1,679 | 10,900 (0%) | 0% | 9.4 | 15,799 | Common Stock |
| Great Elm Capital Corp | Matt Kaplan | CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.50 per share. | 15 Jun 2022 | 1,000 | 2,000 (0%) | 0% | 12.5 | 12,500 | Common Stock |
| Great Elm Capital Corp | Matt Kaplan | CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2022 | 1,000 | 0 | - | - | Subscription Rights | |
| Nuvectis Pharma Inc | Matthew L. Kaplan | Director | Purchase of securities on an exchange or from another person at price $ 17.47 per share. | 12 May 2022 | 1,823 | 35,760 | - | 17.5 | 31,848 | Common Stock |
| Nuvectis Pharma Inc | Matthew L. Kaplan | Director | Purchase of securities on an exchange or from another person at price $ 15.96 per share. | 12 May 2022 | 1,177 | 33,937 | - | 16.0 | 18,785 | Common Stock |
| Nuvectis Pharma Inc | Matthew L. Kaplan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 15,000 | 15,000 | - | - | Stock Options (right to buy) | |
| Great Elm Capital Corp | Matt Kaplan | CEO and President | Purchase of securities on an exchange or from another person at price $ 14.00 per share. | 08 Mar 2022 | 1,000 | 1,000 (0%) | 0% | 14 | 14,000 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges